According to publisher, The European clinical nutrition market is a robust and flourishing sector, catering to individuals with medical conditions or those unable to meet their nutritional needs through regular diet.

Market Insights

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


Market Value and Growth: The European clinical nutrition market is estimated to reach a value of USD 31.39 billion by 2029, growing at a CAGR of 8.35%. This growth is fueled by an aging population, increasing healthcare expenditure, and a growing focus on preventative healthcare.

Growth Drivers: Several factors are propelling the European market forward:

Ageing Population:

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Europe has a rapidly aging population, with a significant portion exceeding 65 years old. This age group is more susceptible to age-related conditions like sarcopenia (muscle loss) and malnutrition, increasing the demand for clinical nutrition products.
Example: Specialized high-protein oral nutritional supplements (ONS) can help elderly individuals maintain muscle mass and improve overall health.
Emphasis on Chronic Disease Management:

Chronic diseases like diabetes, cancer, and gastrointestinal disorders are prevalent in Europe. Clinical nutrition plays a crucial role in managing these conditions by providing targeted nutrient support.
Example: Enteral feeding tubes can be used for patients with digestive issues or undergoing cancer treatment, ensuring they receive the necessary nutrients for recovery.
Government Initiatives:

European governments are increasingly promoting preventative healthcare and early intervention for chronic diseases. This includes promoting the use of clinical nutrition products for at-risk populations.
Example: The UK government might launch public health campaigns to raise awareness about the benefits of ONS for individuals recovering from surgery.
Market Dynamics

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval


The European clinical nutrition market is a dynamic environment influenced by several key trends:

Focus on Reimbursement:
Reimbursement policies for clinical nutrition products vary across European countries. Manufacturers need to navigate these complexities to ensure market access.
Example: A company might develop a new enteral feeding formula with clinical evidence to support reimbursement approval in specific European markets.

Rise of Value-Based Healthcare:
Similar to North America, Europe is witnessing a shift towards value-based healthcare models that emphasize cost-effectiveness and improved patient outcomes. Clinical nutrition can contribute by preventing complications and reducing hospital readmission rates.
Example: Hospitals in Germany might adopt personalized nutrition plans using clinical nutrition products to improve patient outcomes and reduce healthcare costs.

Stringent Regulatory Environment:
Europe enforces strict regulations regarding the safety and quality of medical devices, including clinical nutrition products. Manufacturers must comply with these regulations to operate within the market.
Example: The European Union (EU) mandates compliance with directives like the Medical Devices Regulation (MDR) for all clinical nutrition products sold in the region.

Market Segments

The European clinical nutrition market can be segmented based on various criteria:

Product Type:

The market offers a wide range of clinical nutrition products, including enteral nutrition, parenteral nutrition, and oral nutritional supplements.
Application:
Clinical nutrition products cater to various medical conditions, such as malnutrition, cancer, gastrointestinal disorders, and metabolic diseases.

Regional Analysis

While Europe functions as a single market, there are variations in terms of market size, product preferences, and reimbursement policies across different countries:

Western Europe:
Western European countries, like Germany, France, and the UK, hold the dominant market share due to their larger economies, higher healthcare spending, and established healthcare infrastructure.
Example: The German market sees a high demand for enteral feeding products for patients in hospitals and long-term care facilities.

Eastern Europe:
Eastern Europe's market is experiencing growth, with increasing demand for clinical nutrition products, particularly in mid-range and luxury healthcare settings.
Example: Countries like Poland and Hungary are witnessing a rise in demand for ONS for elderly individuals and those recovering from illnesses.

Key Developments

The European clinical nutrition market is experiencing continuous innovation:

Telehealth Integration:
Telehealth platforms are being integrated with clinical nutrition management in Europe. This allows for remote monitoring and dietary consultations with patients.
Example: A patient in France with a chronic digestive condition might connect with a dietitian virtually who can assess their nutritional needs and recommend appropriate enteral feeding solutions.

Focus on Personalized Nutrition:

The market is witnessing a shift towards personalized nutrition solutions in Europe. Clinicians are increasingly tailoring nutritional plans based on individual needs and medical conditions.

Table of Contents

  • 1 Introduction 9
  • 1.1 Industry Definition and Research Scope 9
  • 1.1.1 Industry Definition 9
  • 1.1.2 Research Scope 10
  • 1.2 Research Methodology 13
  • 1.2.1 Overview of Market Research Methodology 13
  • 1.2.2 Market Assumption 14
  • 1.2.3 Secondary Data 14
  • 1.2.4 Primary Data 14
  • 1.2.5 Data Filtration and Model Design 15
  • 1.2.6 Market Size/Share Estimation 16
  • 1.2.7 Research Limitations 17
  • 1.3 Executive Summary 18
  • 2 Market Overview and Dynamics 21
  • 2.1 Market Size and Forecast 21
  • 2.1.1 Impact of COVID-19 on World Economy 22
  • 2.1.2 Impact of COVID-19 on the Market 25
  • 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
  • 2.2 Major Growth Drivers 31
  • 2.3 Market Restraints and Challenges 37
  • 2.4 Emerging Opportunities and Market Trends 40
  • 2.5 Porter’s Fiver Forces Analysis 44
  • 3 Segmentation of Europe Market by Substrate 48
  • 3.1 Market Overview by Substrate 48
  • 3.2 Carbohydrates 50
  • 3.3 Lipids 51
  • 3.4 Proteins & Amino Acids 52
  • 3.5 Water & Electrolyte 53
  • 3.6 Dietary Fiber 54
  • 3.7 Antioxidants 55
  • 3.8 Other Substrates 56
  • 4 Segmentation of Europe Market by Administration Route 57
  • 4.1 Market Overview by Administration Route 57
  • 4.2 Oral or Enteral Administration 59
  • 4.2.1 Oral Nutrition Supplements 60
  • 4.2.2 Tube Feeding 61
  • 4.3 Parenteral Administration 62
  • 4.3.1 Supplemental Parenteral Nutrition 64
  • 4.3.2 Total Parenteral Nutrition 65
  • 4.3.3 All-in-One System 66
  • 4.3.4 Multiple Bottle System 67
  • 5 Segmentation of Europe Market by Dosage Form 68
  • 5.1 Market Overview by Dosage Form 68
  • 5.2 Powder 70
  • 5.3 Liquid 71
  • 5.4 Solid and Semi-solid 72
  • 6 Segmentation of Europe Market by Therapeutic Area 73
  • 6.1 Market Overview by Therapeutic Area 73
  • 6.2 Malnutrition 75
  • 6.3 Metabolic Disorders 76
  • 6.4 Gastrointestinal Disorders 77
  • 6.5 Cancer 78
  • 6.6 Neurology 79
  • 6.7 Renal Diseases 80
  • 6.8 Respiratory Diseases 81
  • 6.9 Other Therapeutic Areas 82
  • 7 Segmentation of Europe Market by End User 83
  • 7.1 Market Overview by End User 83
  • 7.2 Infant 85
  • 7.3 Children 86
  • 7.4 Adult 87
  • 7.5 Geriatrics 88
  • 8 Segmentation of Europe Market by Healthcare Setting 89
  • 8.1 Market Overview by Healthcare Setting 89
  • 8.2 Hospitals 91
  • 8.3 Long-term Care Facilities (LTC) 92
  • 8.4 Homecare 93
  • 8.5 Inpatient Rehabilitation Facilities 94
  • 8.6 Other Healthcare Settings 95
  • 9 Segmentation of Europe Market by Distribution Channel 96
  • 9.1 Market Overview by Distribution Channel 96
  • 9.2 Institutional Sales 98
  • 9.3 Supermarkets & Hypermarkets 99
  • 9.4 Pharmacies 100
  • 9.5 Drug Stores 101
  • 9.6 Online Channels 102
  • 9.7 Other Distribution Channels 103
  • 10 European Market 2022-2032 by Country 104
  • 10.1 Overview of European Market 104
  • 10.2 Germany 107
  • 10.3 U.K. 109
  • 10.4 France 111
  • 10.5 Spain 113
  • 10.6 Italy 115
  • 10.7 Netherlands 117
  • 10.8 Rest of European Market 119
  • 11 Competitive Landscape 121
  • 11.1 Overview of Key Vendors 121
  • 11.2 New Product Launch, Partnership, Investment, and M&A 124
  • 11.3 Company Profiles 125
  • Abbott Nutrition 125
  • B Braun Melsungen Ag 127
  • BASF SE 130
  • Baxter International Inc. 133
  • Claris Lifesciences Ltd. 136
  • Fresenius Kabi Ag 137
  • Lonza Group AG 140
  • Nestlé S.A. 144
  • Nutricia Ltd 149
  • Perrigo Company Plc 153
  • RELATED REPORTS 156
  • ?



Table 1. Snapshot of Europe Clinical Nutrition Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in Europe Clinical Nutrition Market 40
Table 7. Europe Clinical Nutrition Market by Substrate, 2022-2032, $ mn 48
Table 8. Europe Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 57
Table 9. Europe Clinical Nutrition Market: Oral or Enteral Administration by Type, 2022-2032, $ mn 59
Table 10. Europe Clinical Nutrition Market: Parenteral Administration by Type, 2022-2032, $ mn 63
Table 11. Europe Clinical Nutrition Market by Dosage Form, 2022-2032, $ mn 68
Table 12. Europe Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 73
Table 13. Europe Clinical Nutrition Market by End User, 2022-2032, $ mn 83
Table 14. Europe Clinical Nutrition Market by Healthcare Setting, 2022-2032, $ mn 89
Table 15. Europe Clinical Nutrition Market by Distribution Channel, 2022-2032, $ mn 96
Table 16. Europe Clinical Nutrition Market by Country, 2022-2032, $ mn 106
Table 17. Germany Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 108
Table 18. Germany Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 108
Table 19. Germany Clinical Nutrition Market by End User, 2022-2032, $ mn 108
Table 20. U.K. Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 110
Table 21. U.K. Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 110
Table 22. U.K. Clinical Nutrition Market by End User, 2022-2032, $ mn 110
Table 23. France Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 112
Table 24. France Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 112
Table 25. France Clinical Nutrition Market by End User, 2022-2032, $ mn 112
Table 26. Spain Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 114
Table 27. Spain Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 114
Table 28. Spain Clinical Nutrition Market by End User, 2022-2032, $ mn 114
Table 29. Italy Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 116
Table 30. Italy Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 116
Table 31. Italy Clinical Nutrition Market by End User, 2022-2032, $ mn 116
Table 32. Netherlands Clinical Nutrition Market by Administration Route, 2022-2032, $ mn 118
Table 33. Netherlands Clinical Nutrition Market by Therapeutic Area, 2022-2032, $ mn 118
Table 34. Netherlands Clinical Nutrition Market by End User, 2022-2032, $ mn 118
Table 35. Clinical Nutrition Market in Rest of Europe by Country, 2022-2032, $ mn 120
Table 36. Abbott Nutrition: Company Snapshot 125
Table 37. Abbott Nutrition: Business Segmentation 126
Table 38. Abbott Nutrition: Product Portfolio 126
Table 39. B Braun Melsungen Ag: Company Snapshot 127
Table 40. B Braun Melsungen Ag: Business Segmentation 128
Table 41. B Braun Melsungen Ag: Revenue by Region 128
Table 42. B Braun Melsungen Ag: Product Portfolio 129
Table 43. BASF: Company Snapshot 130
Table 44. BASF: Business Segmentation 131
Table 45. BASF: Revenue by Region 131
Table 46. BASF: Product Portfolio 132
Table 47. Baxter International Inc.: Company Snapshot 133
Table 48. Baxter International Inc.: Business Segmentation 133
Table 49. Baxter International Inc.: Revenue by Region 134
Table 50. Baxter International Inc.: Product Portfolio 134
Table 51. Claris Lifesciences Ltd.: Company Snapshot 136
Table 52. Fresenius Kabi Ag: Company Snapshot 137
Table 53. Fresenius Kabi Ag: Business Segmentation 138
Table 54. Fresenius Kabi Ag: Revenue by Region 138
Table 55. Fresenius Kabi Ag: Product Portfolio 139
Table 56. Lonza Group: Company Snapshot 140
Table 57. Lonza Group: Business Segmentation in 2018 141
Table 58. Lonza Group: Product Portfolio 141
Table 59. Lonza Group: Revenue by Region in 2018 142
Table 60. Nestlé S.A.: Company Snapshot 144
Table 61. Nestlé S.A.: Business Segmentation 144
Table 62. Nestlé S.A.: Product Portfolio 145
Table 63. Nestlé S.A.: Revenue, 2018-2020, $ bn 147
Table 64. Nutricia Ltd: Company Snapshot 149
Table 65. Nutricia Ltd: Business Segmentation 150
Table 66. Nutricia Ltd: Revenue by Region 150
Table 67. Nutricia Ltd: Product Portfolio 151
Table 68. Perrigo Company Plc: Company Snapshot 153
Table 69. Perrigo Company Plc: Business Segmentation 154
Table 70. Perrigo Company Plc: Revenue by Region 154
Table 71. Perrigo Company Plc: Product Portfolio 154



Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 18
Figure 4. Europe Clinical Nutrition Market, 2022-2032, $ mn 21
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of Europe Clinical Nutrition Market 31
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 8. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 9. Forecast of World Middle-class Population by Region, 2015-2030, million 35
Figure 10. Primary Restraints and Impact Factors of Europe Clinical Nutrition Market 37
Figure 11. Investment Opportunity Analysis 41
Figure 12. Porter’s Fiver Forces Analysis of Europe Clinical Nutrition Market 44
Figure 13. Breakdown of Europe Clinical Nutrition Market by Substrate, 2022-2032, % of Revenue 49
Figure 14. Europe Addressable Market Cap in 2023-2032 by Substrate, Value ($ mn) and Share (%) 49
Figure 15. Europe Clinical Nutrition Market by Substrate: Carbohydrates, 2022-2032, $ mn 50
Figure 16. Europe Clinical Nutrition Market by Substrate: Lipids, 2022-2032, $ mn 51
Figure 17. Europe Clinical Nutrition Market by Substrate: Proteins & Amino Acids, 2022-2032, $ mn 52
Figure 18. Europe Clinical Nutrition Market by Substrate: Water & Electrolyte, 2022-2032, $ mn 53
Figure 19. Europe Clinical Nutrition Market by Substrate: Dietary Fiber, 2022-2032, $ mn 54
Figure 20. Europe Clinical Nutrition Market by Substrate: Antioxidants, 2022-2032, $ mn 55
Figure 21. Europe Clinical Nutrition Market by Substrate: Other Substrates, 2022-2032, $ mn 56
Figure 22. Breakdown of Europe Clinical Nutrition Market by Administration Route, 2022-2032, % of Sales Revenue 58
Figure 23. Europe Addressable Market Cap in 2023-2032 by Administration Route, Value ($ mn) and Share (%) 58
Figure 24. Europe Clinical Nutrition Market by Administration Route: Oral or Enteral Administration, 2022-2032, $ mn 59
Figure 25. Europe Clinical Nutrition Market by Oral or Enteral Administration: Oral Nutrition Supplements, 2022-2032, $ mn 60
Figure 26. Europe Clinical Nutrition Market by Oral or Enteral Administration: Tube Feeding, 2022-2032, $ mn 61
Figure 27. Europe Clinical Nutrition Market by Administration Route: Parenteral Administration, 2022-2032, $ mn 62
Figure 28. Europe Clinical Nutrition Market by Parenteral Administration: Supplemental Parenteral Nutrition, 2022-2032, $ mn 64
Figure 29. Europe Clinical Nutrition Market by Parenteral Administration: Total Parenteral Nutrition, 2022-2032, $ mn 65
Figure 30. Europe Clinical Nutrition Market by Parenteral Administration: All-in-One System, 2022-2032, $ mn 66
Figure 31. Europe Clinical Nutrition Market by Parenteral Administration: Multiple Bottle System, 2022-2032, $ mn 67
Figure 32. Breakdown of Europe Clinical Nutrition Market by Dosage Form, 2022-2032, % of Sales Revenue 69
Figure 33. Europe Addressable Market Cap in 2023-2032 by Dosage Form, Value ($ mn) and Share (%) 69
Figure 34. Europe Clinical Nutrition Market by Dosage Form: Powder, 2022-2032, $ mn 70
Figure 35. Europe Clinical Nutrition Market by Dosage Form: Liquid, 2022-2032, $ mn 71
Figure 36. Europe Clinical Nutrition Market by Dosage Form: Solid and Semi-solid, 2022-2032, $ mn 72
Figure 37. Breakdown of Europe Clinical Nutrition Market by Therapeutic Area, 2022-2032, % of Revenue 74
Figure 38. Europe Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 74
Figure 39. Europe Clinical Nutrition Market by Therapeutic Area: Malnutrition, 2022-2032, $ mn 75
Figure 40. Europe Clinical Nutrition Market by Therapeutic Area: Metabolic Disorders, 2022-2032, $ mn 76
Figure 41. Europe Clinical Nutrition Market by Therapeutic Area: Gastrointestinal Disorders, 2022-2032, $ mn 77
Figure 42. Europe Clinical Nutrition Market by Therapeutic Area: Cancer, 2022-2032, $ mn 78
Figure 43. Europe Clinical Nutrition Market by Therapeutic Area: Neurology, 2022-2032, $ mn 79
Figure 44. Europe Clinical Nutrition Market by Therapeutic Area: Renal Diseases, 2022-2032, $ mn 80
Figure 45. Europe Clinical Nutrition Market by Therapeutic Area: Respiratory Diseases, 2022-2032, $ mn 81
Figure 46. Europe Clinical Nutrition Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 82
Figure 47. Breakdown of Europe Clinical Nutrition Market by End User, 2022-2032, % of Revenue 84
Figure 48. Europe Addressable Market Cap in 2023-2032 by End User, Value ($ mn) and Share (%) 84
Figure 49. Europe Clinical Nutrition Market by End User: Infant, 2022-2032, $ mn 85
Figure 50. Europe Clinical Nutrition Market by End User: Children, 2022-2032, $ mn 86
Figure 51. Europe Clinical Nutrition Market by End User: Adult, 2022-2032, $ mn 87
Figure 52. Europe Clinical Nutrition Market by End User: Geriatrics, 2022-2032, $ mn 88
Figure 53. Breakdown of Europe Clinical Nutrition Market by Healthcare Setting, 2022-2032, % of Revenue 89
Figure 54. Europe Addressable Market Cap in 2023-2032 by Healthcare Setting, Value ($ mn) and Share (%) 90
Figure 55. Europe Clinical Nutrition Market by Healthcare Setting: Hospitals, 2022-2032, $ mn 91
Figure 56. Europe Clinical Nutrition Market by Healthcare Setting: Long-term Care Facilities (LTC), 2022-2032, $ mn 92
Figure 57. Europe Clinical Nutrition Market by Healthcare Setting: Homecare, 2022-2032, $ mn 93
Figure 58. Europe Clinical Nutrition Market by Healthcare Setting: Inpatient Rehabilitation Facilities, 2022-2032, $ mn 94
Figure 59. Europe Clinical Nutrition Market by Healthcare Setting: Other Healthcare Settings, 2022-2032, $ mn 95
Figure 60. Breakdown of Europe Clinical Nutrition Market by Distribution Channel, 2022-2032, % of Revenue 97
Figure 61. Europe Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%) 97
Figure 62. Europe Clinical Nutrition Market by Distribution Channel: Institutional Sales, 2022-2032, $ mn 98
Figure 63. Europe Clinical Nutrition Market by Distribution Channel: Supermarkets & Hypermarkets, 2022-2032, $ mn 99
Figure 64. Europe Clinical Nutrition Market by Distribution Channel: Pharmacies, 2022-2032, $ mn 100
Figure 65. Europe Clinical Nutrition Market by Distribution Channel: Drug Stores, 2022-2032, $ mn 101
Figure 66. Europe Clinical Nutrition Market by Distribution Channel: Online Channels, 2022-2032, $ mn 102
Figure 67. Europe Clinical Nutrition Market by Distribution Channel: Other Distribution Channels, 2022-2032, $ mn 103
Figure 68. Breakdown of European Clinical Nutrition Market by Country, 2022 and 2032, % of Revenue 105
Figure 69. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 106
Figure 70. Clinical Nutrition Market in Germany, 2022-2032, $ mn 107
Figure 71. Clinical Nutrition Market in U.K., 2022-2032, $ mn 109
Figure 72. Clinical Nutrition Market in France, 2022-2032, $ mn 111
Figure 73. Clinical Nutrition Market in Spain, 2022-2032, $ mn 113
Figure 74. Clinical Nutrition Market in Italy, 2022-2032, $ mn 115
Figure 75. Clinical Nutrition Market in Netherlands, 2022-2032, $ mn 117
Figure 76. Clinical Nutrition Market in Rest of Europe, 2022-2032, $ mn 119
Figure 77. Growth Stage of Europe Clinical Nutrition Industry over the Forecast Period 121
Figure 78. Nestlé S.A.: Revenue by Region, 2018 147
Logo

Europe Clinical Nutrition Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.